Esketamine (intravenous)

esketamine · Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Esketamine (intravenous), covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression [Phase 2]